Share Price and Basic Stock Data
Last Updated: October 22, 2025, 3:33 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Cinevista Ltd, operating in the Entertainment & Media industry, currently trades at ₹18.9 with a MarketCap of ₹109 Cr. The company boasts a robust Return on Equity (ROE) of 47.7% and a healthy Return on Capital Employed (ROCE) of 19.9%. Furthermore, its Operating Profit Margin (OPM) stands at an impressive 41.90%. However, Cinevista Ltd faces significant challenges, with a negative Net Profit of -₹32 Cr and a Price-to-Book Value (P/BV) ratio of -9.17x, indicating the market values its assets below book value.One key strength of Cinevista Ltd lies in its high ROE and ROCE, reflecting efficient use of capital and strong profitability. Additionally, the company’s substantial promoter holding of 67.43% signals confidence in its long-term prospects. On the flip side, the firm’s negative Net Profit and low P/BV ratio raise concerns about its financial health and market perception. Looking ahead, Cinevista Ltd’s outlook could improve with a strategic shift towards cost optimization and revenue diversification, while risks remain elevated due to its high borrowing levels and negative profit trajectory. Retail investors should closely monitor the company’s efforts to turn around its financial performance and enhance shareholder value in the competitive Entertainment & Media sector.Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cinevista Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hathway Bhawani Cabletel & Datacom Ltd | 12.4 Cr. | 15.2 | 21.7/13.0 | 77.2 | 2.22 | 0.00 % | 3.38 % | 2.25 % | 10.0 |
| G V Films Ltd | 61.5 Cr. | 0.33 | 0.82/0.32 | 0.61 | 0.00 % | 2.36 % | 1.71 % | 1.00 | |
| Encash Entertainment Ltd | 11.3 Cr. | 29.0 | / | 20.8 | 0.00 % | 4.70 % | 4.70 % | 10.0 | |
| Diksat Transworld Ltd | 211 Cr. | 120 | 148/100 | 3,508 | 14.4 | 0.00 % | 2.82 % | 0.24 % | 10.0 |
| Cyber Media (India) Ltd | 27.2 Cr. | 17.4 | 30.1/11.0 | 302 | 7.47 | 0.00 % | 4.52 % | % | 10.0 |
| Industry Average | 2,068.48 Cr | 126.29 | 447.72 | 36.46 | 0.19% | 15.72% | 12.74% | 6.15 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.80 | 0.00 | 0.00 | 0.43 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 11.47 | 4.63 |
| Expenses | 0.43 | 0.50 | 1.92 | 38.30 | 1.80 | 1.20 | 1.06 | 0.29 | 0.73 | 0.97 | 1.30 | 26.60 | 2.69 |
| Operating Profit | -0.43 | -0.50 | -1.12 | -38.30 | -1.80 | -0.77 | -1.06 | -0.28 | -0.71 | -0.95 | -1.27 | -15.13 | 1.94 |
| OPM % | -140.00% | -179.07% | -2,800.00% | -3,550.00% | -4,750.00% | -4,233.33% | -131.91% | 41.90% | |||||
| Other Income | 0.18 | 0.59 | 0.00 | 0.90 | 0.07 | 0.32 | 0.02 | 0.02 | 0.02 | 0.09 | 0.01 | 0.03 | 0.00 |
| Interest | 1.32 | 1.56 | 1.95 | 2.69 | 1.06 | 0.56 | 0.63 | 0.77 | 0.85 | 1.04 | 0.95 | 0.92 | 0.90 |
| Depreciation | 0.04 | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 |
| Profit before tax | -1.61 | -1.51 | -3.09 | -40.10 | -2.81 | -1.03 | -1.70 | -1.06 | -1.57 | -1.93 | -2.25 | -16.08 | 0.99 |
| Tax % | 0.00% | 0.00% | 0.00% | -45.71% | 0.00% | 0.00% | 0.00% | 86.79% | 0.00% | 0.00% | 0.00% | 60.88% | 0.00% |
| Net Profit | -1.61 | -1.52 | -3.09 | -21.77 | -2.80 | -1.03 | -1.69 | -1.97 | -1.57 | -1.93 | -2.25 | -25.87 | 0.99 |
| EPS in Rs | -0.28 | -0.26 | -0.54 | -3.79 | -0.49 | -0.18 | -0.29 | -0.34 | -0.27 | -0.34 | -0.39 | -4.50 | 0.17 |
Last Updated: August 1, 2025, 10:40 pm
Below is a detailed analysis of the quarterly data for Cinevista Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4.63 Cr.. The value appears to be declining and may need further review. It has decreased from 11.47 Cr. (Mar 2025) to 4.63 Cr., marking a decrease of 6.84 Cr..
- For Expenses, as of Jun 2025, the value is 2.69 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 26.60 Cr. (Mar 2025) to 2.69 Cr., marking a decrease of 23.91 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.94 Cr.. The value appears strong and on an upward trend. It has increased from -15.13 Cr. (Mar 2025) to 1.94 Cr., marking an increase of 17.07 Cr..
- For OPM %, as of Jun 2025, the value is 41.90%. The value appears strong and on an upward trend. It has increased from -131.91% (Mar 2025) to 41.90%, marking an increase of 173.81%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.03 Cr..
- For Interest, as of Jun 2025, the value is 0.90 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.92 Cr. (Mar 2025) to 0.90 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -16.08 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 17.07 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 60.88% (Mar 2025) to 0.00%, marking a decrease of 60.88%.
- For Net Profit, as of Jun 2025, the value is 0.99 Cr.. The value appears strong and on an upward trend. It has increased from -25.87 Cr. (Mar 2025) to 0.99 Cr., marking an increase of 26.86 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.17. The value appears strong and on an upward trend. It has increased from -4.50 (Mar 2025) to 0.17, marking an increase of 4.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 59 | 41 | 24 | 21 | 35 | 19 | 1 | 1 | 1 | 0 | 12 | 16 |
| Expenses | 46 | 54 | 40 | 25 | 32 | 31 | 17 | 3 | 4 | 40 | 4 | 30 | 32 |
| Operating Profit | 6 | 5 | 1 | -1 | -11 | 5 | 2 | -2 | -3 | -40 | -4 | -18 | -15 |
| OPM % | 11% | 9% | 2% | -5% | -55% | 13% | 12% | -304% | -297% | -4,942% | -882% | -156% | -95% |
| Other Income | 0 | 0 | 5 | 7 | 15 | -0 | 0 | -2 | -7 | 1 | 0 | 0 | 0 |
| Interest | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 7 | 3 | 4 | 4 |
| Depreciation | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -1 | 0 | 0 | -2 | -1 | -3 | -10 | -15 | -46 | -7 | -22 | -19 |
| Tax % | 28% | 15% | 0% | 25% | 1% | 2% | 1% | 0% | 11% | -40% | 14% | 45% | |
| Net Profit | 0 | -1 | 0 | 0 | -2 | -1 | -3 | -10 | -16 | -28 | -8 | -32 | -29 |
| EPS in Rs | 0.02 | -0.16 | 0.01 | 0.03 | -0.43 | -0.23 | -0.53 | -1.66 | -2.87 | -4.87 | -1.31 | -5.51 | -5.06 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 50.00% | -200.00% | -233.33% | -60.00% | -75.00% | 71.43% | -300.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -50.00% | -250.00% | -33.33% | 173.33% | -15.00% | 146.43% | -371.43% |
Cinevista Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -10% |
| 3 Years: | 124% |
| TTM: | 3411% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -364% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -15% |
| 3 Years: | -26% |
| Last Year: | -48% |
Last Updated: September 5, 2025, 2:00 am
Balance Sheet
Last Updated: October 10, 2025, 1:50 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 149 | 148 | 146 | 146 | 144 | 143 | 137 | 127 | 106 | 78 | 70 | 39 |
| Borrowings | 24 | 22 | 28 | 40 | 37 | 41 | 46 | 52 | 63 | 78 | 24 | 25 |
| Other Liabilities | 14 | 16 | 13 | 7 | 18 | 23 | 20 | 11 | 5 | 7 | 72 | 70 |
| Total Liabilities | 199 | 198 | 199 | 205 | 211 | 218 | 215 | 202 | 186 | 175 | 178 | 146 |
| Fixed Assets | 146 | 146 | 142 | 141 | 137 | 137 | 134 | 113 | 126 | 125 | 125 | 22 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 7 | 13 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 53 | 52 | 56 | 64 | 73 | 80 | 81 | 85 | 54 | 43 | 40 | 121 |
| Total Assets | 199 | 198 | 199 | 205 | 211 | 218 | 215 | 202 | 186 | 175 | 178 | 146 |
Below is a detailed analysis of the balance sheet data for Cinevista Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
- For Reserves, as of Mar 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 70.00 Cr. (Mar 2024) to 39.00 Cr., marking a decrease of 31.00 Cr..
- For Borrowings, as of Mar 2025, the value is 25.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 24.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 70.00 Cr.. The value appears to be improving (decreasing). It has decreased from 72.00 Cr. (Mar 2024) to 70.00 Cr., marking a decrease of 2.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 146.00 Cr.. The value appears to be improving (decreasing). It has decreased from 178.00 Cr. (Mar 2024) to 146.00 Cr., marking a decrease of 32.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 103.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 11.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 121.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 121.00 Cr., marking an increase of 81.00 Cr..
- For Total Assets, as of Mar 2025, the value is 146.00 Cr.. The value appears to be declining and may need further review. It has decreased from 178.00 Cr. (Mar 2024) to 146.00 Cr., marking a decrease of 32.00 Cr..
Notably, the Reserves (39.00 Cr.) exceed the Borrowings (25.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | -17.00 | -27.00 | -41.00 | -48.00 | -36.00 | -44.00 | -54.00 | -66.00 | -118.00 | -28.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 117 | 85 | 150 | 300 | 172 | 112 | 180 | 4,700 | 2,491 | -0 | -0 | 0 |
| Inventory Days | 222 | 2,346 | ||||||||||
| Days Payable | 88 | 17 | ||||||||||
| Cash Conversion Cycle | 117 | 85 | 150 | 300 | 172 | 112 | 180 | 4,700 | 2,491 | 134 | -0 | 2,329 |
| Working Capital Days | 227 | 192 | 290 | 742 | 769 | 496 | 890 | 35,145 | 16,958 | 4,681 | -44,513 | 1,274 |
| ROCE % | 2% | 2% | 2% | 2% | 1% | 2% | 1% | 1% | -2% | -22% | -3% | -20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| Diluted EPS (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| Cash EPS (Rs.) | -5.34 | -1.26 | -4.73 | -2.75 | -1.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.77 | -1.99 | -0.71 | 4.04 | 7.58 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.58 | 13.94 | 15.22 | 19.97 | 23.51 |
| Revenue From Operations / Share (Rs.) | 1.96 | 0.07 | 0.13 | 0.17 | 0.14 |
| PBDIT / Share (Rs.) | -3.04 | -0.58 | -6.50 | -0.50 | 0.35 |
| PBIT / Share (Rs.) | -3.07 | -0.60 | -6.52 | -0.56 | 0.21 |
| PBT / Share (Rs.) | -3.71 | -1.12 | -7.86 | -2.52 | -1.62 |
| Net Profit / Share (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| NP After MI And SOA / Share (Rs.) | -5.37 | -1.27 | -4.75 | -2.80 | -1.62 |
| PBDIT Margin (%) | -155.16 | -784.10 | -4784.16 | -294.43 | 248.70 |
| PBIT Margin (%) | -156.52 | -805.26 | -4798.60 | -325.02 | 153.61 |
| PBT Margin (%) | -189.13 | -1494.46 | -5789.27 | -1452.62 | -1138.45 |
| Net Profit Margin (%) | -273.90 | -1702.56 | -3498.06 | -1616.55 | -1138.69 |
| NP After MI And SOA Margin (%) | -273.90 | -1702.56 | -3498.06 | -1616.55 | -1138.69 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | -69.35 | -21.36 |
| Return on Capital Employeed (%) | -24.05 | -3.35 | -33.96 | -1.83 | 0.67 |
| Return On Assets (%) | -21.71 | -4.20 | -15.98 | -8.88 | -4.72 |
| Long Term Debt / Equity (X) | -0.61 | -2.02 | -5.56 | 0.00 | 0.00 |
| Total Debt / Equity (X) | -0.62 | -2.06 | -5.56 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.07 | 0.00 | 0.00 | 0.01 | 0.00 |
| Current Ratio (X) | 1.59 | 0.28 | 0.36 | 15.71 | 7.44 |
| Quick Ratio (X) | 0.05 | 0.05 | 0.09 | 1.78 | 1.55 |
| Inventory Turnover Ratio (X) | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | -4.76 | -1.14 | -5.11 | -0.65 | 0.49 |
| Interest Coverage Ratio (Post Tax) (X) | -7.40 | -1.47 | -2.68 | -1.09 | 0.30 |
| Enterprise Value (Cr.) | 105.54 | 129.83 | 89.34 | 78.79 | 35.79 |
| EV / Net Operating Revenue (X) | 9.14 | 294.73 | 111.68 | 77.25 | 42.71 |
| EV / EBITDA (X) | -5.89 | -37.59 | -2.33 | -26.24 | 17.17 |
| MarketCap / Net Operating Revenue (X) | 7.06 | 243.81 | 88.00 | 77.74 | 42.96 |
| Price / BV (X) | -2.04 | -9.17 | -16.73 | 3.34 | 0.80 |
| Price / Net Operating Revenue (X) | 7.06 | 244.37 | 88.13 | 77.80 | 42.97 |
| EarningsYield | -0.38 | -0.06 | -0.39 | -0.20 | -0.26 |
After reviewing the key financial ratios for Cinevista Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For Cash EPS (Rs.), as of Mar 25, the value is -5.34. This value is below the healthy minimum of 3. It has decreased from -1.26 (Mar 24) to -5.34, marking a decrease of 4.08.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.77. It has decreased from -1.99 (Mar 24) to -6.77, marking a decrease of 4.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.58. It has decreased from 13.94 (Mar 24) to 8.58, marking a decrease of 5.36.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.96. It has increased from 0.07 (Mar 24) to 1.96, marking an increase of 1.89.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -3.04. This value is below the healthy minimum of 2. It has decreased from -0.58 (Mar 24) to -3.04, marking a decrease of 2.46.
- For PBIT / Share (Rs.), as of Mar 25, the value is -3.07. This value is below the healthy minimum of 0. It has decreased from -0.60 (Mar 24) to -3.07, marking a decrease of 2.47.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.71. This value is below the healthy minimum of 0. It has decreased from -1.12 (Mar 24) to -3.71, marking a decrease of 2.59.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 2. It has decreased from -1.27 (Mar 24) to -5.37, marking a decrease of 4.10.
- For PBDIT Margin (%), as of Mar 25, the value is -155.16. This value is below the healthy minimum of 10. It has increased from -784.10 (Mar 24) to -155.16, marking an increase of 628.94.
- For PBIT Margin (%), as of Mar 25, the value is -156.52. This value is below the healthy minimum of 10. It has increased from -805.26 (Mar 24) to -156.52, marking an increase of 648.74.
- For PBT Margin (%), as of Mar 25, the value is -189.13. This value is below the healthy minimum of 10. It has increased from -1,494.46 (Mar 24) to -189.13, marking an increase of 1,305.33.
- For Net Profit Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 5. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -273.90. This value is below the healthy minimum of 8. It has increased from -1,702.56 (Mar 24) to -273.90, marking an increase of 1,428.66.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -24.05. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -24.05, marking a decrease of 20.70.
- For Return On Assets (%), as of Mar 25, the value is -21.71. This value is below the healthy minimum of 5. It has decreased from -4.20 (Mar 24) to -21.71, marking a decrease of 17.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 0.2. It has increased from -2.02 (Mar 24) to -0.61, marking an increase of 1.41.
- For Total Debt / Equity (X), as of Mar 25, the value is -0.62. This value is within the healthy range. It has increased from -2.06 (Mar 24) to -0.62, marking an increase of 1.44.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.07. It has increased from 0.00 (Mar 24) to 0.07, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 1.59, marking an increase of 1.31.
- For Quick Ratio (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.18, marking an increase of 0.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -4.76. This value is below the healthy minimum of 3. It has decreased from -1.14 (Mar 24) to -4.76, marking a decrease of 3.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -7.40. This value is below the healthy minimum of 3. It has decreased from -1.47 (Mar 24) to -7.40, marking a decrease of 5.93.
- For Enterprise Value (Cr.), as of Mar 25, the value is 105.54. It has decreased from 129.83 (Mar 24) to 105.54, marking a decrease of 24.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 3. It has decreased from 294.73 (Mar 24) to 9.14, marking a decrease of 285.59.
- For EV / EBITDA (X), as of Mar 25, the value is -5.89. This value is below the healthy minimum of 5. It has increased from -37.59 (Mar 24) to -5.89, marking an increase of 31.70.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 243.81 (Mar 24) to 7.06, marking a decrease of 236.75.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has increased from -9.17 (Mar 24) to -2.04, marking an increase of 7.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.06. This value exceeds the healthy maximum of 3. It has decreased from 244.37 (Mar 24) to 7.06, marking a decrease of 237.31.
- For EarningsYield, as of Mar 25, the value is -0.38. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.38, marking a decrease of 0.32.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cinevista Ltd:
- Net Profit Margin: -273.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -24.05% (Industry Average ROCE: 15.72%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 12.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -7.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 447.72)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -0.62
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -273.9%
About the Company - Qualitative Analysis
Cinevista Ltd. is a Public Limited Listed company incorporated on 07/05/1997 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L92130MH1997PLC107871 and registration number is 107871. Currently Company is involved in the business activities of Motion picture, video and television programme production, sound recording and music publishing activities.. Company's Total Operating Revenue is Rs. 11.54 Cr. and Equity Capital is Rs. 11.49 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Entertainment & Media | 1, Silver Croft, Off. T.P.S. III, Mumbai Maharashtra 400050 | helpdesk@cinevistaas.com http://www.cinevistaas.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishen Malhotra | Chairman & Wholetime Director |
| Mr. Sunil Mehta | Vice Chairman & Mng.Director |
| Mrs. Vinita Concessio | Non Executive Director |
| Mrs. Rebekah Peter Martyres | Ind. Non-Executive Director |
| Mr. Dhiraj Labhchand Chaudhry | Ind. Non-Executive Director |
| Mr. Mahrukh Shavak Chikliwala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Cinevista Ltd?
Cinevista Ltd's intrinsic value (as of 23 October 2025) is 51.38 which is 171.85% higher the current market price of 18.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 109 Cr. market cap, FY2025-2026 high/low of 24.9/12.9, reserves of ₹39 Cr, and liabilities of 146 Cr.
What is the Market Cap of Cinevista Ltd?
The Market Cap of Cinevista Ltd is 109 Cr..
What is the current Stock Price of Cinevista Ltd as on 23 October 2025?
The current stock price of Cinevista Ltd as on 23 October 2025 is 18.9.
What is the High / Low of Cinevista Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cinevista Ltd stocks is 24.9/12.9.
What is the Stock P/E of Cinevista Ltd?
The Stock P/E of Cinevista Ltd is .
What is the Book Value of Cinevista Ltd?
The Book Value of Cinevista Ltd is 8.80.
What is the Dividend Yield of Cinevista Ltd?
The Dividend Yield of Cinevista Ltd is 0.00 %.
What is the ROCE of Cinevista Ltd?
The ROCE of Cinevista Ltd is 19.9 %.
What is the ROE of Cinevista Ltd?
The ROE of Cinevista Ltd is 47.7 %.
What is the Face Value of Cinevista Ltd?
The Face Value of Cinevista Ltd is 2.00.